- Home
- ANSS vs WAT Comparison
ANSS vs WAT Comparison
Compare ANSS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSS
- WAT
- Stock Information
- Founded
- ANSS 1970
- WAT 1958
- Country
- ANSS United States
- WAT United States
- Employees
- ANSS N/A
- WAT N/A
- Industry
- ANSS Computer Software: Prepackaged Software
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ANSS Technology
- WAT Industrials
- Exchange
- ANSS Nasdaq
- WAT Nasdaq
- Market Cap
- ANSS 29.4B
- WAT 20.8B
- IPO Year
- ANSS 1996
- WAT 1995
- Fundamental
- Price
- ANSS $375.69
- WAT $353.04
- Analyst Decision
- ANSS Buy
- WAT Buy
- Analyst Count
- ANSS 2
- WAT 15
- Target Price
- ANSS $352.50
- WAT $385.27
- AVG Volume (30 Days)
- ANSS 634.3K
- WAT 468.7K
- Earning Date
- ANSS 07-30-2025
- WAT 08-04-2025
- Dividend Yield
- ANSS N/A
- WAT N/A
- EPS Growth
- ANSS 35.35
- WAT 8.23
- EPS
- ANSS 6.74
- WAT 11.02
- Revenue
- ANSS $2,583,095,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- ANSS $11.48
- WAT $6.11
- Revenue Next Year
- ANSS $10.05
- WAT $6.44
- P/E Ratio
- ANSS $55.60
- WAT $32.04
- Revenue Growth
- ANSS 15.98
- WAT 2.57
- 52 Week Low
- ANSS $275.06
- WAT $292.06
- 52 Week High
- ANSS $380.07
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- ANSS 77.75
- WAT 53.68
- Support Level
- ANSS $346.87
- WAT $343.83
- Resistance Level
- ANSS $368.00
- WAT $360.00
- Average True Range (ATR)
- ANSS 6.12
- WAT 9.67
- MACD
- ANSS 2.82
- WAT 0.39
- Stochastic Oscillator
- ANSS 92.28
- WAT 53.24
About ANSS ANSYS Inc.
Ansys is an engineering software company that provides simulation capabilities for structural, fluids, semiconductor power, embedded software, optical, and electromagnetic properties. Ansys employs over 4,000 people and serves over 50,000 customers globally.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.